trending Market Intelligence /marketintelligence/en/news-insights/trending/vzugkt7ebdghfoway0zmaw2 content esgSubNav
In This List

Bellicum Pharmaceuticals names CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Bellicum Pharmaceuticals names CFO

Bellicum Pharmaceuticals Inc. named Atabak Mokari CFO, effective Dec. 19.

Mokari was CFO and vice president corporate development at IRIDEX Corp., an ophthalmic medical technology company.

Houston-based Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders.